Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menstrual Blood Stem Cells for Poor Ovarian Responders
NCT05703308Phase 3Completed
- Sponsor
- Avicenna Research Institute
- Start
- Jun 2020
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous menstrual blood-derived mesenchymal stromal cells in poor ovarian response (POR), sponsored by Avicenna Research Institute. Started Jun 2020; status: completed.
02
Drugs
autologous menstrual blood-derived mesenchymal stromal cells
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT05703308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05703308.